Palatin Technologies

0 followers

‌

Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin peptide receptor system.

Industries

Biotechnology, Pharmaceutical

Headquarters

Cranbury, United States

Employees

51-200

Links

Org chart

Carl Spana

CEO, President & Director

Carl Spana

Collapse

Stephen T. Wills

COO, CFO, Treasurer & Secretary

Stephen A. Slusher

Chief Legal Officer

Samrat Sisodia

VP, Regulatory Affairs & Quality Assurance

Michael B. Raizman

Chief Medical Officer

John Dodd

SVP, Preclinical Development

Paul Kayne

VP, Biological Sciences

J. Don Wang

VP, Product Development

Don Wang

Vice President, Prod Dev (CMC)

Johna Lucas

Chief Medical Officer

John Prendergast

Co-Founder and Chairman of the Board

Teams

Leadership Team

11 members

Research and Development

6 members

Clinical Operations and Regulatory Affairs

4 members

Similar companies

Entrada Therapeutics

1 follower

Scholar Rock

1 follower

Vial

5 followers

Bristol-Myers Squibb

175 followers

Thermo Fisher Scientific

156 followers

Viatris

33 followers

GRAIL

27 followers

Catalent

17 followers

Abbott

277 followers

Cytokinetics

11 followers

Formation Bio

2 followers

Explore companies